AMG NewTech

 

 

 

 

 

 

 

 

 

 

 

In-Depth Market Research and Trend Analysis

Covering Innovative and Emerging Technologies

News

Healthcare and Biomedical Engineering


The market for tissue repair and engineering procedures for cancer treatment is forecast to grow at a 16.1% CAGR through 2020

 

Tissue repair and engineering procedures for cancer treatment (TREPCs) are based on the use of implantable and transplantable materials made from body tissues and biomaterials and are used for restoring, replacing or regenerating tissues affected by cancer. Chemotherapeutic products are not included in this definition.

 

Existing and emerging TREPCs focus on cancer treatment for all body organ systems, including the urinary, reproductive, gastrointestinal, respiratory, cardiac, hematic, skeletal and cranium-maxillofacial, ophthalmic, neurological, muscle, and dermal systems. 

 

In general, materials for tissue repair and engineering are categorized as autografts (obtained from the same patient), allografts (obtained from another individual), xenografts (obtained from an animal), and synthetic materials (partially or completely man-made). TREPCs are primarily based on autologous or allogeneic stem cells and on synthetic materials. Synthetic materials are prepared in the form of microspheres, nanoparticles, nanofibers, pastes, gels, solid components, and injectable solutions and emulsions, and are made from a variety of materials including ceramics, glass, glass-ceramics, polymers, metal and alloys, or composites.

 

TREPC materials of recent development integrate pharmaceutical compounds (i.e., drugs), biological compounds (e.g., DNA, proteins, enzymes, and peptides) and engineered microorganisms (e.g., bacteria) with the function to improve biocompatibility, bioactivity and cell regeneration speed. 

 

Relevant market players in the field of TREPCs are Celgene, Mesoblast, BioTime, Cellerant, Gamida Cell, GlobalStem, NeoStem, and TriStem.

 

As shown in the table below, the global TREPC market, which includes costs for materials and surgical procedures but excludes costs associated with hospitalization stays and medical follow-ups, is estimated to reach $800.9 million in 2015. Stem cells account for the largest share of the market at 93.9% of the total, whereas all the other procedures are currently in the clinical trial stage and represent a much smaller share of the market. 

 

AMG NewTech forecasts that the TREPC market will rise at a CAGR of 16.1% through 2020, driven primarily by the expanded use of stem cell therapies and by increased penetration of innovative nanoparticle-based regenerative products. Examples are biodegradable polymeric nanoparticles that deliver targeted drugs and also act as scaffolds for new cell growth. 



Global market for tissue repair and engineering procedures for cancer treatment by material type, 2015 through 2020.


Material Type

Revenues ($ Millions)

CAGR%

2015-2020

2015

2020

Stem cells

751.8

1,525.3

15.2

Nanoparticles

  44.0

   154.8

28.6

Microspheres

    4.7

       7.0

  9.7

Others

    0.4

       0.7

12.1

Total

800.9

1,687.8

16.1


Source: AMG NewTech

 

Back to Main Topics

  


Keywords: tissue, repair, engineering, cancer, treatment, nanoparticles, market 

 

Add a Comment

(Enter the numbers shown in the above image)